Menu
 
Research menu
Jump to menu

Publications:  Prof David Wald

Wald DS, Martin AC(2020). Decision to reject screening for familial hypercholesterolaemia is flawed. Arch Dis Child
10.1136/archdischild-2020-319168
Wald D, Hadyanto S, Bestwick J(2020). Should Fractional Flow Reserve follow Angiographic Visual Inspection to guide Preventive PCI in STEMI?. European Heart Journal - Quality of Care and Clinical Outcomes
10.1093/ehjqcco/qcaa012
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63745
Wald DS, Bestwick JP, Kelly P(2020). The effect of the Montgomery judgment on settled claims against the National Health Service due to failure to inform before giving consent to treatment. QJM
10.1093/qjmed/hcaa082
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64586
Wald DS, Casey-Gillman O, Comer K, Mansell JS, Teo H, Mouyis K, Kelham M, Chan F et al.(2020). Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative. Heart
10.1136/heartjnl-2019-316227
Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, Almahmeed W, Alonso R, Al-Rasadi K et al.(2020). Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. JAMA Cardiology vol. 5, (2) 217-229.
10.1001/jamacardio.2019.5173
Wald DS, Bestwick JP(2020). Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies. Atherosclerosis vol. 293, 57-61.
10.1016/j.atherosclerosis.2019.11.028
Orlev A, Abdel-Gadir A, Tait G, Bestwick JP, Almagor Y, Wald D (2019). Comparison of Radial With Femoral Access Coronary Angiography in Patients With Previous Coronary Artery Bypass Surgery. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. vol. 74, B773-B773.
10.1016/j.jacc.2019.08.934
Ramaswami U, Humphries SE, Priestley-Barnham L, Green P, Wald DS, Capps N, Anderson M, Dale P et al.(2019). Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care. Atherosclerosis vol. 290, 1-8.
10.1016/j.atherosclerosis.2019.09.005
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60918
Wald D, Chambers J, Bestwick J, Wald N(2019). Randomized Crossover Trial of Phosphate-binding Medication on Serum Phosphate Levels in Patients With Aortic Stenosis. Clinical Therapeutics: the international peer-reviewed journal of drug therapy
10.1016/j.clinthera.2019.08.004
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60724
Wald DS, Kelly P(2019). Medical Consent; striking the right balance between shared decision-making and shared responsibility. QJM
10.1093/qjmed/hcz229
https://qmro.qmul.ac.uk/xmlui/handle/123456789/61087
Orlev A, Abdel-Gadir A, Tait G, Bestwick J, Wald D(2019). Coronary artery bypass angiography: the exception to the radial access rule?. British Journal of Cardiology vol. 26, (3) 114-118.
10.5837/bjc.2019.030
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58846
Wald D, Singh P, Cobb V (2019). 51 Animation-supported consent in patients undergoing coronary angiography and angioplasty. Heart. Conference: British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019 vol. 105,
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60601
Hadyanto S, Curtis M, Wald D (2019). 63 Impact of randomised trial evidence and esc guideline change on practice of preventive pci in patients with ST-elevation myocardial infarction. Heart. Conference: British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019 vol. 105,
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60587
Singh P, Wald D, Cobb V (2019). ANIMATION-SUPPORTED CONSENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY AND ANGIOPLASTY. HEART. vol. 105, A44-A44.
10.1136/heartjnl-2019-BCS.49
Hadyanto S, Curtis M, Wald D (2019). IMPACT OF RANDOMISED TRIAL EVIDENCE AND ESC GUIDELINE CHANGE ON PRACTICE OF PREVENTIVE PCI IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION. HEART. vol. 105, A54-A54.
10.1136/heartjnl-2019-BCS.61
WALD DAVID, BESTWICK J(2019). Ethnic access to child–parent screening for familial hypercholesterolaemia. European Journal of Preventive Cardiology
10.1177/2047487319843668
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58792
Wald N, Wald D, Kellermann AL(2018). When Guidelines Cause Hypertension. American Journal of Medicine vol. 131, (12) 1402-1404.
10.1016/j.amjmed.2018.06.007
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54166
WALD D, WALD NJ(2018). Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Journal of Medical Screening
10.1177/0969141318796856
https://qmro.qmul.ac.uk/xmlui/handle/123456789/49283
Wald DS, Tsolaki E, Bestwick JP, Bertazzo S(2018). Scanning electron microscopy for blood micro-crystals in aortic stenosis patients. PLoS One vol. 13, (8) e0202282-e0202282.
10.1371/journal.pone.0202282
https://qmro.qmul.ac.uk/xmlui/handle/123456789/49605
WALD D, Wald B, Radford A, SHIPOLINI A(2018). The sternal wire code; solving the problem of missing coronary artery bypass graft records during cardiac catheterization. IJC Heart and Vasculature vol. 19, 37-40.
10.1016/j.ijcha.2018.04.004
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36903
WALD D, Williams S, Bangash F, bestwick J(2018). Watchful waiting in aortic stenosis: the problem of acute decompensation. American Journal of Medicine vol. 131, (2) 173-177.
10.1016/j.amjmed.2017.08.027
https://qmro.qmul.ac.uk/xmlui/handle/123456789/26026
WALD D, BESTWICK J(2018). Association between serum calcium, serum phosphate and aortic stenosis with implications for prevention. European Journal of Preventive Cardiology vol. 25, (5) 551-556.
10.1177/2047487318756131
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34995
WALD D, Wald B, Shipoloni A (2017). Angiography after CABG Surgery; Solving the problem of missing surgical records with a sternal wire code. Heart. vol. 103, A47-A48.
10.1136/heartjnl-2017-311726.61
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45960
Wald NJ, Wald DS(2017). Blood pressure and cardiovascular outcomes: a closer look. The Lancet vol. 389, (10076)
10.1016/S0140-6736(17)30834-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45959
WALD D, Bangash F, Morris J, Wald N(2017). Mortality from aortic stenosis – prospective study of serum calcium and phosphate. Journal of Internal Medicine vol. 281, (4) 407-411.
10.1111/joim.12593
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18362
Wald DS, Bestwick JP, Wald NJ(2017). The authors reply. New England Journal of Medicine vol. 376, (5) 499-500.
10.1056/NEJMc1615365
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45957
WALD D, Bestwick J, Morris J, Whyte K, Jenkins L, Wald N(2016). Child-Parent Familial Hypercholesterolemia Screening in Primary Care. New England Journal of Medicine vol. 375, (17) 1628-1637.
10.1056/NEJMoa1602777
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14854
Wald DS, Bestwick JP(2016). Preventive percutaneous coronary intervention and aspiration thrombectomy-updates in the management of ST-elevation myocardial infarction. J Thorac Dis vol. 8, (8) 1908-1912.
10.21037/jtd.2016.07.73
https://qmro.qmul.ac.uk/xmlui/handle/123456789/53683
Wald DS, Butt S, Bestwick JP(2016). The Reply. Am J Med vol. 129, (2)
10.1016/j.amjmed.2015.10.004
Wald DS, Butt S, Bestwick JP(2015). One-way versus two-way text messaging on improving medication adherence: Meta-analysis of randomized trials. American Journal of Medicine vol. 128, (10) 1139.e1-1139.e5.
10.1016/j.amjmed.2015.05.035
Wald DS, Butt S, Bestwick JP(2015). One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med vol. 128, (10) 1139.e1-1139.e5.
10.1016/j.amjmed.2015.05.035
Wald DS, Bangash FA, Bestwick JP(2015). Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction. Eur J Intern Med vol. 26, (2) 127-130.
10.1016/j.ejim.2015.01.014
Wald DS, Bestwick JP(2015). Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction - The Primacy of Randomised Trials. Interv Cardiol vol. 10, (1) 32-34.
10.15420/icr.2015.10.1.32
Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ(2014). Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT Trial). PLoS ONE vol. 9, (12)
10.1371/journal.pone.0114268
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31043
Fung K, Edmondson S, Wald DS(2014). Atrial myxoma masquerading as Takayasu's arteritis. JRSM Open vol. 5, (11)
10.1177/2054270414550977
Bangash FA, Antbring CR, Wald DS(2014). Novel low density lipoprotein receptor variant linked to early onset acute myocardial infarction in a patient with familial hypercholesterolaemia. JRSM Open vol. 5, (4)
10.1177/2042533313518917
Wald DS, Morris JK, Wald NJ(2014). The authors reply. New England Journal of Medicine vol. 370, (3)
10.1056/NEJMc1314696
Wald DS, Morris JK, Wald NJ, Investigators PRAMI(2014). Preventive Angioplasty in Myocardial Infarction REPLY. NEW ENGLAND JOURNAL OF MEDICINE vol. 370, (3) 283-283.
10.1056/NEJMc1314277
Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, Berry C, Oldroyd KG et al.(2013). Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med vol. 369, (12) 1115-1123.
10.1056/NEJMoa1305520
Wald DS(2013). The polypill and the prevention of heart attacks and strokes by Caroline Telfer. Future Cardiol vol. 9, (4) 465-466.
10.2217/fca.13.29
Raiman L, Wald D, Bestwick J (2013). INTERACT Investigation of Text Message Reminders on Adherence to Cardiac Treatment - Pilot Study. CIRCULATION. vol. 127,
Wald DS, Bestwick JP, Wald NJ(2012). Homocysteine as a cause of ischemic heart disease: the door remains open. Clin Chem vol. 58, (10) 1488-1490.
10.1373/clinchem.2012.191791
Naderi SH, Bestwick JP, Wald DS(2012). Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med vol. 125, (9) 882-7.e1.
10.1016/j.amjmed.2011.12.013
Wald DS, Simmonds MC, Morris JK, Rothwell PM, Wald NJ(2012). Cost-effectiveness of diagnosis of high blood pressure in primary care. Lancet vol. 379, (9817) 709-710.
10.1016/S0140-6736(12)60302-X
Wald DS, Wald NJ(2012). Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach. Journal of Evaluation in Clinical Practice vol. 18, (3) 612-615.
10.1111/j.1365-2753.2011.01637.x
Wald DS, Morris JK, Wald NJ(2012). Randomized Polypill crossover trial in people aged 50 and over. PLoS One vol. 7, (7)
10.1371/journal.pone.0041297
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5311
Morris JK, Wald DS, Wald NJ(2012). The evaluation of cascade testing for familial hypercholesterolemia. American Journal of Medical Genetics, Part A vol. 158 A, (1) 78-84.
10.1002/ajmg.a.34368
Morris JK, Wald DS, Wald NJ(2012). The evaluation of cascade testing for familial hypercholesterolemia. Am J Med Genet A vol. 158A, (1) 78-84.
10.1002/ajmg.a.34368
Wald DS, Kasturiratne A, Godoy A, Ma L, Bestwick JP, Brewer N, Wald NJ(2011). Child-parent screening for familial hypercholesterolemia. J Pediatr vol. 159, (5) 865-867.
10.1016/j.jpeds.2011.06.006
Wald DS, Kasturiratne A, Simmonds M(2011). Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement vol. 7, (4) 412-417.
10.1016/j.jalz.2010.08.234
Wald DS, Morris JK, Wald NJ(2011). Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS One vol. 6, (2)
10.1371/journal.pone.0016473
https://qmro.qmul.ac.uk/xmlui/handle/123456789/4722
Wald DS, Wald NJ(2011). The Polypill in the prevention of cardiovascular disease. Prev Med vol. 52, (1) 16-17.
10.1016/j.ypmed.2010.11.015
Wald DS(2010). Blood pressure, left ventricular hypertrophy and cardiovascular disease. Heart vol. 96, (13)
10.1136/hrt.2010.196501
Wald DS, Kasturiratne A, Simmonds M(2010). Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med vol. 123, (6) 522-527.e2.
10.1016/j.amjmed.2010.01.017
Wald NJ, Wald DS(2010). The polypill concept. Postgrad Med J vol. 86, (1015) 257-260.
10.1136/hrt.2009.186429
Wald DS, Bestwick JP(2010). C-reactive protein measurement and cardiovascular disease. Lancet vol. 375, (9720)
10.1016/S0140-6736(10)60468-0
Wald DS, Wald NJ(2010). The polypill in the primary prevention of cardiovascular disease. Fundam Clin Pharmacol vol. 24, (1) 29-35.
10.1111/j.1472-8206.2009.00795.x
Wald NJ, Wald DS(2010). The polypill concept. Heart vol. 96, (1) 1-4.
10.1136/hrt.2009.186429
Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS(2009). Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals. QJM vol. 102, (12) 843-849.
10.1093/qjmed/hcp127
Wald DS(2009). Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure. ANNALS OF INTERNAL MEDICINE vol. 151, (4) Article ARTN JC2-11,
Wald DS(2009). Position Paper 2: Familial Hypercholesterolaemia: Do we care and who should do the caring?. Journal of the Royal College of Physicians of Edinburgh
Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ(2009). Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med vol. 122, (3) 290-300.
10.1016/j.amjmed.2008.09.038
Wald DS, Bestwick JP(2009). Carotid ultrasound screening for coronary heart disease: results based on a meta-analysis of 18 studies and 44,861 subjects. J Med Screen vol. 16, (3) 147-154.
10.1258/jms.2009.009038
Wald DS, Bestwick JP, Morton G, Drummond L, Jenkins N, Khodabakhsh P, Curzen NP(2009). Combining carotid intima-media thickness with carotid plaque on screening for coronary heart disease. J Med Screen vol. 16, (3) 155-159.
10.1258/jms.2009.009039
Wald DS, Kasturiratne A, Bestwick JP(2009). The value of C-reactive protein in screening for future coronary heart disease events. J Med Screen vol. 16, (4) 212-214.
10.1258/jms.2009.009087
Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ(2008). A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Clin Ther vol. 30, (11) 2030-2039.
10.1016/j.clinthera.2008.11.003
Wald D(2008). Commentary: Controversies in NICE guidance on familial hypercholesterolaemia. BMJ vol. 337,
10.1136/bmj.a1304
Wald NJ, Morris JK, Young NJ, Wald DS(2008). Meta-analysis audit trail. Lancet vol. 371, (9612)
10.1016/S0140-6736(08)60266-4
Wald DS, Bestwick JP, Wald NJ(2007). Familial hypercholesterolaemia: screening needs a fresh approach. BMJ vol. 335, (7628) 1007-1008.
10.1136/bmj.39395.370278.80
Wald DS, Bestwick JP, Wald NJ(2007). Screening needs a fresh approach. BMJ vol. 335, (7628) 1007-1008.
10.1136/bmj.39395.370278.80
Wald D(2007). In response to Warren and Durrington. CLIN MED vol. 7, (5) 525-526.
Wald DS, Morton G, Walker K, Iosson N, Curzen NP(2007). Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease. Ann Pharmacother vol. 41, (10) 1644-1647.
10.1345/aph.1K232
Wald DS, Bestwick JP, Wald NJ(2007). Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ vol. 335, (7620)
10.1136/bmj.39300.616076.55
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5499
Wald DS(2007). Problems with performance related pay in primary care. BMJ vol. 335, (7619)
10.1136/bmj.39329.384329.BE
Wald DS(2007). The future of coronary heart disease prevention. Clin Med (Lond) vol. 7, (4) 392-396.
10.7861/clinmedicine.7-4-392
Bellenger NG, Swallow R, Wald DS, Court I, Calver AL, Dawkins KD, Curzen N(2007). Haemodynamic significance of ostial side branch nipping following percutaneous intervention at bifurcations: a pressure wire pilot study. Heart vol. 93, (2) 249-250.
10.1136/hrt.2006.088690
Wald DS, Wald NJ, Morris JK, Law M(2006). Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ vol. 333, (7578) 1114-1117.
10.1136/bmj.39000.486701.68
Wald DS, Law M(2006). Hypertrophic cardiomyopathy. Sudden death is rare in young people with hypertrophic cardiomyopathy. BMJ vol. 333, (7558) 96-97.
10.1136/bmj.333.7558.96-b
Zahedi RG, Wald DS, Ohri S(2006). Carney complex. Ann Thorac Surg vol. 82, (1) 320-322.
10.1016/j.athoracsur.2005.07.099
Sambu N, Wald DS, Seddon M, Simpson IA(2006). Undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery. Heart vol. 92, (5) 697-698.
10.1136/hrt.2005.069914
Wald DS(2005). Serum homocysteine and coronary heart disease. Women and Heart Disease, Editors: Wenger, Collins, Edition. 2nd Edn, Martin Dunitz / Taylor & Francis Group (Oxford),
Wald DS, Law M, Morris JK(2004). Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications. Int J Cardiol vol. 97, (3) 479-484.
10.1016/j.ijcard.2003.11.014
Wald DS(2004). Bureaucracy of ethics applications. BMJ vol. 329, (7460) 282-284.
10.1136/bmj.329.7460.282
Wald DS, Law M, Morris JK(2004). The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening. Eur J Cardiovasc Prev Rehabil vol. 11, (3) 250-253.
10.1097/01.hjr.0000129742.15346.ab
Wald DS(2004). Vitamin supplementation and risk of stroke. JAMA vol. 291, (18)
10.1001/jama.291.18.2191-b
Wald DS, Milne S, Martin M, Chinn R(2004). Beta blocker therapy for patients in primary care: meeting National Service Framework standards. Br J Cardiol vol. 11, 408-412.
Wald DS, Law M, Morris J, Wald NJ(2003). Folate and risk of cardiovascular disease. Study results were misinterpreted. BMJ vol. 326, (7397)
10.1136/bmj.326.7397.1035/a
Wald DS, Gray HH(2003). Restrictive cardiomyopathy in systemic amyloidosis. QJM vol. 96, (5) 380-382.
10.1093/qjmed/hcg065
Wald DS(2003). Homocysteine and cardiovascular disease: implications for clinical practice. New Generalist vol. 1, (2) 13-15.
Wald DS, Law M, Morris J(2003). Serum homocysteine and the severity of coronary artery disease. Thromb Res vol. 111, (1-2) 55-57.
10.1016/j.thromres.2003.08.015
Wald DS, Law M, Morris JK(2002). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ vol. 325, (7374)
10.1136/bmj.325.7374.1202
Wald DS, More RS, Martin M, Hughes L, Reid CJ(2002). Can beta blockers be safely initiated at home in patients with heart failure?. QJM vol. 95, (1) 55-56.
10.1093/qjmed/95.1.55
Wald DS(2002). Hypertrophic & dilated cardiomyopathy - The facts. JOURNAL OF MEDICAL SCREENING vol. 9, (3) 144-144.
10.1136/jms.9.3.144
Wald DS(2002). Screening for cardiovascular disease: choice is irrelevant when screening is not worthwhile. BMJ vol. 325, 78-80.
Wald N, LAW MR, Wald D(2002). The serum folate response to the US mandatory fortification of grain products with folic acid. Arch Int Med vol. 162, (19) 2254-2254.
10.1001/archinte.162.19.2254
Wald NJ, Law MR, Morris JK, Wald DS(2001). Quantifying the effect of folic acid. Lancet vol. 358, (9298) 2069-2073.
10.1016/s0140-6736(01)07104-5
Wald DS, Hennessy E, Law M(2001). Do folate induced changes in serum homocysteine affect leukocyte concentrations in patients with ischaemic heart disease?. Thromb Res vol. 104, (5) 343-345.
10.1016/s0049-3848(01)00386-3
Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J(2001). Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med vol. 161, (5) 695-700.
10.1001/archinte.161.5.695
Wald DS, Hughs L, More RS, Reid CJ(2001). Adverse effects of beta blockers on first dose administration in heart failure. Clin Scie vol. 101, (5)
Wasld DS(2001). Homocysteine screening for ischaemic heart disease. J Med Screen vol. 8,
Wald DS, Dewhurst AG, Holman RA(2001). Medical Assessment Units: A realistic solution?. Br J Health Care Management vol. 7, (7) 273-277.
Ward DS, Bishop L, Wald NJ, Law M, Hennessey E, Weir D, McPartlin J, Scott J(2000). Randomised trial of folic acid on serum homocysteine levels in people with ischaemic heart disease. CIRCULATION vol. 102, (18) 869-869.
Wald D, Quiney J, Murphy CF, Reid CJ(2000). How useful is the measurement of cardiac Troponins in deciding the management of patients admitted to hospital with chest pain?. Br J Cardiol vol. 7, (5) 272-276.
Wald DS(1999). Screening for hypertrophic cardiomyopathy. J Med Screen vol. 6, 159-162.
Wald DS(1998). Atrial fibrillation and screening for the prevention of stroke. J Med Screen vol. 5,
Wald DS(1998). Perceived contraindications to thrombolysis in acute myocardial infarction: A survey at a teaching hospital. J Accident & Emergency Med (BMJ Publications) vol. 15, 329-331.
Wald DS(1997). Thrombolysis after myocardial infarction. Lancet vol. 349,
Wald DS, Weinreb JC, Newstead G(1996). MRI-Guided Fine Needle Aspiration of breast lesions: initial experience. J Comput Assist Tomogr vol. 20, (1) 1-8.
Return to top